Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
48

Summary

Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
  • Chronic Myelogenous Leukemia
  • Hodgkin Disease
  • Hodgkin's Disease
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Neoplasm
  • Non Hodgkin Lymphoma
  • Non Hodgkin's Lymphoma
Type
Interventional
Phase
Phase 2
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02639559
Collaborators
BioLineRx, Ltd.
Investigators
Principal Investigator: Geoffrey Uy, M.D. Washington University School of Medicine